Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03870048 · ClinicalTrials.gov registry record · NA
tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03870048: Completed NA study, sponsored by University of Iowa.
NCT03870048 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03870048, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) on neuropathic pain and fatigue in people with MS. The investigators will conduct tDCS or sham on 5 consecutive days. They will evaluate pain and fatigue with specific questionnaires and measure fatigability with an isokinetic device. The research question is whether tDCS can lessen neuropathic pain and increase fatigue resistance in people with MS. It is hypothesized, that less neuropathic pain and increased fatigue resistance after the tDCS sessions.
Primary Outcome
The participant is asked to use items to rate their pain as it usually feels. They have to indicate a number which represents their pain on each scale. For example, if someone has no burning pain, the person would rate the first item "0". If the person has the worst burning pain imaginable, he/she would rate it "100". If neither of those fits his/her pain because it is in between, the participant has to choose a number which fits his/her pain.
Interventions
- DEVICE transcranial direct current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2020-03-30 |
| Phase | NA |
What the finished NCT03870048 record still lists
NCT03870048 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which transcranial direct current stimulation is the first listed.
NCT03870048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03870048 about?
NCT03870048 is a clinical study titled "tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis". The purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) on neuropathic pain and fatigue in people with MS. The investigators will conduct tDCS or sham on 5 consecutive days. They will evaluate pain and fatigue with specific questionnaires and measure...
What is the current status of trial NCT03870048?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2019-04-15. Estimated completion is 2020-03-30.
What interventions are being tested in trial NCT03870048?
The interventions under investigation include: transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT03870048?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03870048's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI